Report Detail
Global Acute Myeloid Testing Market By Biomarker type [genetic acute myeloid leukemia (AML) biomarker, epigenetic acute myeloid leukemia (AML) biomarker and proteomic acute myeloid leukemia (AML) biomarker],By Product & service [Services, Assay kits], By Technology[PCR (Polymerase Chain Reaction),IHC (Immunohistochemistry),NGS (Next-Generation Sequencing),cytogenetics and Others], By End user[Clinical laboratories, Hospitals, Academic & research institutes, Cancer diagnostic institutes and Othe
- RnM4285130 |
- 10 February, 2021 |
- Global |
- 213 Pages |
- Transilience Market Research |
- Healthcare
Global Acute Myeloid Testing Market 2020 By Biomarker type [genetic acute myeloid leukemia (AML) biomarker, epigenetic acute myeloid leukemia (AML) biomarker and proteomic acute myeloid leukemia (AML) biomarker],By Product & service [Services, Assay kits], By Technology[PCR (Polymerase Chain Reaction),IHC (Immunohistochemistry),NGS (Next-Generation Sequencing),cytogenetics and Others], By End user[Clinical laboratories, Hospitals, Academic & research institutes, Cancer diagnostic institutes and Others]:Global Forecast to 2026 and COVID-19 Impact Outlook
Acute Myeloid Testing Market is valued at 492.25 USD Million in 2019 and expected to reach USD 1,133.99 Million by 2026 with the CAGR of 12.68% over the forecast period.
Scope of the report
This report analyses the global market for Acute Myeloid Testing. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players
NeoGenomics Laboratories Inc.,QIAGEN,Invivoscribe Inc.,Illumina Inc.,Laboratory Corporation of America Holdings,Dr Lal PathLabs,F. Hoffmann-La Roche Ltd,Abbott Laboratories,Thermo Fisher Scientific Inc.,Cancer Genetics Inc. SkylineDx B.V.,ArcherDx Inc.,ARUP Laboratories,ASURAGEN INC.,Mayo Foundation for Medical Education and Research and others
Above mentioned companies were scrutinized to assess competitive landscape of global Acute Myeloid Testing market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period:
(2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Million
This Acute Myeloid Testing market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Biomarker type
o genetic acute myeloid leukemia (AML) biomarker
o epigenetic acute myeloid leukemia (AML) biomarker
o proteomic acute myeloid leukemia (AML) biomarker
• Product & service
o Services
o Assay kits
• Technology
o PCR (Polymerase Chain Reaction)
o IHC (Immunohistochemistry)
o NGS (Next-Generation Sequencing)
o cytogenetics
o Others
• End user
o Clinical laboratories
o Hospitals
o Academic & research institutes
o Cancer diagnostic institutes
o Others
Report Coverage
• An overview of the global Acute Myeloid Testing market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Acute Myeloid Testing market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Acute Myeloid Testing market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Acute Myeloid Testing Market Report
• What is the impact of COVID 19 epidemic on the global Acute Myeloid Testing market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Acute Myeloid Testing market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Acute Myeloid Testing market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
- 3.1. Market Definition
- 3.2. Market Scope
- 3.3. Market Drivers
- 3.4. Market Restraints
- 3.5. Market Opportunities and Trends
- 3.6. Porter’s five force analysis
- 3.7. SWOT Analysis
- 3.8. PEST Analysis
- 3.9. Patent Analysis
- 3.10. Impact of COVID 19 on Global Acute Myeloid Testing Market
4. Acute Myeloid Testing Market, By Biomarker type, Market Size and Forecast 2016 -2026 (USD Million)
- 4.1. Global Acute Myeloid Testing Market By Biomarker type, 2016 -2026 (USD Million)
- 4.1.1. Global Acute Myeloid Testing Market By genetic acute myeloid leukemia (AML) biomarker
- 4.1.2. Global Acute Myeloid Testing Market By epigenetic acute myeloid leukemia (AML) biomarker
- 4.1.3. Global Acute Myeloid Testing Market By proteomic acute myeloid leukemia (AML) biomarker
- 4.2. Global Acute Myeloid Testing Market By Biomarker type Share, 2016 -2026 (%)
5. Acute Myeloid Testing Market, By Technology, Market Size and Forecast 2016 -2026 (USD Million)
- 5.1. Global Acute Myeloid Testing Market By Technology, 2016 -2026 (USD Million)
- 5.1.1. Global Acute Myeloid Testing Market By PCR (Polymerase Chain Reaction)
- 5.1.2. Global Acute Myeloid Testing Market By IHC (Immunohistochemistry)
- 5.1.3. Global Acute Myeloid Testing Market By NGS (Next-Generation Sequencing)
- 5.1.4. Global Acute Myeloid Testing Market By cytogenetics
- 5.1.5. Global Acute Myeloid Testing Market By Others
- 5.2. Global Acute Myeloid Testing Market By Technology Share, 2016 -2026 (%)
6. Acute Myeloid Testing Market, By Product & service, Market Size and Forecast 2016 -2026 (USD Million)
- 6.1. Global Acute Myeloid Testing Market By Product & service, 2016 -2026 (USD Million)
- 6.1.1. Global Acute Myeloid Testing Market By Services
- 6.1.2. Global Acute Myeloid Testing Market By Assay kits
- 6.2. Global Acute Myeloid Testing Market By Product & service Share, 2016 -2026 (%)
7. Acute Myeloid Testing Market, By End user, Market Size and Forecast 2016 -2026 (USD Million)
- 7.1. Global Acute Myeloid Testing Market By End user, 2016 -2026 (USD Million)
- 7.1.1. Global Acute Myeloid Testing Market By Clinical laboratories
- 7.1.2. Global Acute Myeloid Testing Market By Hospitals
- 7.1.3. Global Acute Myeloid Testing Market By Academic & research institutes
- 7.1.4. Global Acute Myeloid Testing Market By Cancer diagnostic institutes
- 7.1.5. Global Acute Myeloid Testing Market By Others
- 7.2. Global Acute Myeloid Testing Market By End user Share, 2016 -2026 (%)
8. Acute Myeloid Testing Market, By Region Market Size and Forecast 2016 -2026
- 8.1. NORTH AMERICA
- 8.1.1. Key Findings
- 8.1.2. Impact of COVID 19
- 8.1.3. Key market trends, growth factors and opportunities
- 8.1.4. North America Acute Myeloid Testing Market by Country 2016 -2026 (USD Million)
- 8.1.5. North America Acute Myeloid Testing Market By Biomarker type 2016 -2026 (USD Million)
- 8.1.6. North America Acute Myeloid Testing Market By Product & service 2016 -2026 (USD Million)
- 8.1.7. North America Acute Myeloid Testing Market By Technology 2016 -2026 (USD Million)
- 8.1.8. North America Acute Myeloid Testing Market By End user 2016 -2026 (USD Million)
- 8.2. EUROPE
- 8.2.1. Key Findings
- 8.2.2. Impact of COVID 19
- 8.2.3. Key market trends, growth factors and opportunities
- 8.2.4. Europe Acute Myeloid Testing Market by Country 2016 -2026 (USD Million)
- 8.2.5. Europe Acute Myeloid Testing Market By Biomarker type 2016 -2026 (USD Million)
- 8.2.6. Europe Acute Myeloid Testing Market By Product & service 2016 -2026 (USD Million)
- 8.2.7. Europe Acute Myeloid Testing Market By Technology 2016 -2026 (USD Million)
- 8.2.8. Europe Acute Myeloid Testing Market By End user 2016 -2026 (USD Million)
- 8.3. ASIA PACIFIC
- 8.3.1. Key Findings
- 8.3.2. Impact of COVID 19
- 8.3.3. Key market trends, growth factors and opportunities
- 8.3.4. Asia Pacific Acute Myeloid Testing Market by Country 2016 -2026 (USD Million)
- 8.3.5. Asia Pacific Acute Myeloid Testing Market By Biomarker type 2016 -2026 (USD Million)
- 8.3.6. Asia Pacific Acute Myeloid Testing Market By Product & service 2016 -2026 (USD Million)
- 8.3.7. Asia Pacific Acute Myeloid Testing Market By Technology 2016 -2026 (USD Million)
- 8.3.8. Asia Pacific Acute Myeloid Testing Market By End user 2016 -2026 (USD Million)
- 8.4. LATIN AMERICA
- 8.4.1. Key Findings
- 8.4.2. Impact of COVID 19
- 8.4.3. Key market trends, growth factors and opportunities
- 8.4.4. Latin America Acute Myeloid Testing Market by Country 2016 -2026 (USD Million)
- 8.4.5. Latin America Acute Myeloid Testing Market By Biomarker type 2016 -2026 (USD Million)
- 8.4.6. Latin America Acute Myeloid Testing Market By Product & service 2016 -2026 (USD Million)
- 8.4.7. Latin America Acute Myeloid Testing Market By Technology 2016 -2026 (USD Million)
- 8.4.8. Latin America Acute Myeloid Testing Market By End user 2016 -2026 (USD Million)
- 8.5. MIDDLE EAST AND AFRICA
- 8.5.1. Key Findings
- 8.5.2. Impact of COVID 19
- 8.5.3. Key market trends, growth factors and opportunities
- 8.5.4. Middle East and Africa Acute Myeloid Testing Market by Country 2016 -2026 (USD Million)
- 8.5.5. Middle East and Africa Acute Myeloid Testing Market By Biomarker type 2016 -2026 (USD Million)
- 8.5.6. Middle East and Africa Acute Myeloid Testing Market By Product & service 2016 -2026 (USD Million)
- 8.5.7. Middle East and Africa Acute Myeloid Testing Market By Technology 2016 -2026 (USD Million)
- 8.5.8. Middle East and Africa Acute Myeloid Testing Market By End user 2016 -2026 (USD Million)
9. Competitive Landscape Analysis
- 9.1. Global Acute Myeloid Testing Market Company Revenue, (USD Million), 2016-2019
- 9.2. Global Acute Myeloid Testing Market Company Share, (%), 2016-2019
10. Company Profiles
- 10.1. NeoGenomics Laboratories Inc.
- 10.2. QIAGEN
- 10.3. Invivoscribe Inc.
- 10.4. Illumina Inc.
- 10.5. Laboratory Corporation of America Holdings
- 10.6. Dr Lal PathLabs
- 10.7. F. Hoffmann-La Roche Ltd
- 10.8. Abbott Laboratories
- 10.9. Thermo Fisher Scientific Inc.
- 10.10. Cancer Genetics Inc. SkylineDx B.V.
- 10.11. ArcherDx Inc.
- 10.12. ARUP Laboratories
- 10.13. ASURAGEN INC.
- 10.14. Mayo Foundation for Medical Education and Research
- 10.15. Others
11. Appendix
12. List of Tables
13. List of Figures
Summary:
Get latest Market Research Reports on Acute Myeloid Testing . Industry analysis & Market Report on Acute Myeloid Testing is a syndicated market report, published as Global Acute Myeloid Testing Market By Biomarker type [genetic acute myeloid leukemia (AML) biomarker, epigenetic acute myeloid leukemia (AML) biomarker and proteomic acute myeloid leukemia (AML) biomarker],By Product & service [Services, Assay kits], By Technology[PCR (Polymerase Chain Reaction),IHC (Immunohistochemistry),NGS (Next-Generation Sequencing),cytogenetics and Others], By End user[Clinical laboratories, Hospitals, Academic & research institutes, Cancer diagnostic institutes and Othe. It is complete Research Study and Industry Analysis of Acute Myeloid Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
